![Palbociclib (PD0332991) Isethionate | CAS:827022-33-3 | CDK4/6 inhibitor,highly selective | High Purity | Manufacturer BioCrick Palbociclib (PD0332991) Isethionate | CAS:827022-33-3 | CDK4/6 inhibitor,highly selective | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCC3698.png)
Palbociclib (PD0332991) Isethionate | CAS:827022-33-3 | CDK4/6 inhibitor,highly selective | High Purity | Manufacturer BioCrick
Sweet Louise - More good news from Pharmac today - they have announced they will fund Ibrance (palbociclib), under an agreement with Pfizer New Zealand 🙌 This follows their announcement earlier this
![Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity | Journal of Medicinal Chemistry Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b01670/asset/images/medium/jm-2017-01670j_0038.gif)
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity | Journal of Medicinal Chemistry
![Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation : r/science Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation : r/science](https://external-preview.redd.it/Grx9IEJeF1RsCQA7-wdnUscUNKM8fWxSjatv5Txehn4.jpg?auto=webp&s=8d84611cabdca33ef7678bdfdbf0ed61056d9e5d)
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation : r/science
![CDK4/6 inhibitors: a brief overview and prospective research directions - RSC Advances (RSC Publishing) DOI:10.1039/D1RA03820F CDK4/6 inhibitors: a brief overview and prospective research directions - RSC Advances (RSC Publishing) DOI:10.1039/D1RA03820F](https://pubs.rsc.org/image/article/2021/RA/d1ra03820f/d1ra03820f-f21_hi-res.gif)